AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.13−0.01 (-0.47%)
Close on Nov 13, 2026Market cap $216.71MP/E –Yield –
AC Immune enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AC Immune's enterprise value was $193.82M on Nov 11, 2026, against $266.07M a year earlier. Over the last 5 years it ranged from $104.74M to $370.17M, with a median of $193.82M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $193.82M | -30.9% |
| 2025 | Dec 31, 2025 | $280.62M | +63.3% |
| 2024 | Dec 31, 2024 | $171.81M | -53.6% |
| 2023 | Dec 29, 2023 | $370.17M | +253.4% |
| 2022 | Dec 30, 2022 | $104.74M | -41.8% |
| 2021 | Dec 31, 2021 | $179.99M | +21.1% |
| 2020 | Dec 31, 2020 | $148.64M | -59.3% |
| 2019 | Dec 31, 2019 | $365.18M | -16.2% |
| 2018 | Dec 31, 2018 | $435.89M | -10.1% |
| 2017 | Dec 29, 2017 | $484.93M | -7.2% |
| 2016 | Dec 30, 2016 | $522.32M | – |
See a number that looks wrong?